Overview

The Tumor 56 gene test bundles 20 targeted genes with 36 chemotherapy-response genes, a compact profile suited to high-volume B2B laboratory sourcing. This article outlines procurement, sample logistics, and partnership considerations for distributors and hospitals working with GIVE LIFE TIME International. The smaller gene set keeps unit cost and turnaround friendly to routine volume.

How It Works

The assay uses a streamlined sequencing and PCR-assisted workflow that keeps turnaround short while covering the most decision-relevant genes. Batched processing supports stable monthly volume for reference laboratories and cross-border clients. Automated extraction lowers hands-on time without sacrificing call quality.

Indications

Community oncology networks and procurement teams use the 56 gene panel for routine profiling where a full four-hundred-plus panel is unnecessary. It fits settings that prioritize speed, cost, and clear targeted-plus-chemotherapy guidance. It is a practical default for first-line decision support.

Specimen & Processing

Formalin-fixed paraffin-embedded tissue or extracted nucleic acid meeting the input minimum is accepted, and plasma is permitted when tissue is scarce. Batched accessioning keeps high-volume submissions efficient. Kits include prepaid return packaging for cross-border clients. Sample identity is confirmed at every handoff, and residual material from the sourcing-focused workflow is retained for optional confirmatory re-analysis.

Storage & Sourcing

Reports are issued as a secure PDF within five to seven working days, with white-label templates on request. GIVE LIFE TIME International manages B2B procurement through tiered pricing, cold-chain logistics, and dedicated account coordination for distributor networks. Client portals return multi-language reports for the Tumor program and support bulk export to hospital information systems.

FAQ

Q: What is the minimum order quantity for B2B clients? A: Flexible monthly batch commitments are available, and volume tiers lower the per-sample price for distributors with steady demand. Trial runs can start below the top tier.

Q: How are samples shipped to the laboratory? A: Samples travel in validated cold-chain packaging with pre-printed labels and customs-ready paperwork for international routes. Collection kits are supplied in advance.

Q: What is the standard reporting turnaround? A: Most batches report within five to seven working days, a schedule chosen to suit routine community oncology workflows. Rush batches can be arranged.

Q: Can the panel be white-labeled for distributors? A: Yes, co-branded requisitions and report templates are supported so partners can present the service under their own label. Logo and contact fields are configurable.